Success Story: Chinese Artificial Intelligence Researcher Advancing Medical Imaging and Healthcare Innovation Secured NIW Approval with NAILG
Client’s Testimonial:
"Thank you for your effort! I highly appreciate it.”
On September 5th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Artificial Intelligence (Approval Notice).
General Field: Artificial Intelligence
Position at the Time of Case Filing: Research Scientist
Country of Origin: China
State of Residence at the Time of Filing: Ohio
Approval Notice Date: September 5th, 2026
Processing Time: 2 months, 18 days (Premium Processing Upgrade Requested)
Case Summary:
“His established track record of success demonstrates his ongoing value to American medicine and the health of the U.S. population.”
This statement is drawn from a recommendation letter highlighting the client’s contributions to artificial intelligence (AI), medical image analysis, cancer research, and healthcare innovation.
The client’s work focuses on developing deep learning and imaging analysis techniques that may help identify adverse disease progression in cancer and other diseases. Holding a Ph.D. in biomedical engineering, the client was employed as a research scientist at a U.S.-based academic medical center at the time of filing, where the client continued developing AI-based tools for pathology, oncology, and clinical decision-support applications.
North America Immigration Law Group (NAILG) prepared the I-140 NIW petition by presenting the client’s work as a nationally important endeavor, not merely a technical research project. The petition showed that the client’s AI-based imaging research could support more accurate disease assessment, improve risk prediction, help clinicians interpret complex medical images, and contribute to more accessible and efficient cancer care.
The client’s record included:
- 10 peer-reviewed journal articles, including 5 first-authored or co-first-authored articles
- 6 peer-reviewed conference papers, including 5 first-authored papers
- 2 preprints, including 1 first-authored preprint
- 350 citations to the client’s published work
- At least 33 completed peer reviews for respected journals in the field
- 5 recommendation letters from experts in the field, including independent advisory opinions
- Research support connected to the National Institutes of Health (NIH)
To demonstrate the client’s significance, we highlighted how independent researchers relied on the client’s findings in later studies involving AI-assisted medical image analysis, cancer diagnosis, medical image interpretation, recurrence prediction, and related biomedical applications. These examples helped show that the client’s research had practical value for scientists and clinicians working to improve cancer detection, disease-risk evaluation, and treatment planning.
The petition also explained the strength of the client’s citation record in context. Multiple papers ranked among highly cited Computer Science articles for their publication years, showing that the client’s work had received recognition beyond ordinary publication and had been repeatedly relied upon by other researchers in artificial intelligence and medical imaging.
By combining publication impact, citation context, peer-review service, funded research involvement, expert letters, current U.S.-based research employment, and future research plans, NAILG demonstrated that the client was well positioned to continue advancing a proposed endeavor with substantial merit and national importance.
USCIS approved the client’s I-140 NIW petition without an RFE, with Premium Processing Upgrade requested. This approval supports the client’s continued contributions to artificial intelligence, medical imaging analysis, cancer research, and AI-enabled clinical decision support in the United States.